Stay updated with breaking news from Stefan Oscarson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) spin-out company, has raised $36m (€32.6m) in series A funding.
Founded by researchers based in UCD and San Francisco, Aer is developing a novel drug to help COPD patients breathe easier.
Company was co-founded by Irishman Prof John Fahy of University of California, San Francisco and Prof Stefan Oscarson of UCD
Aer Therapeutics, a joint University College Dublin and University of California, San Francisco biopharmaceutical spin-out company developing novel in....
Aer Therapeutics, a biopharmaceutical spin-out company has secured $36M (approximately €32.7M) in a Series A round of funding.